Litcius/Paper detail

A first-in-class β-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer

Vasilii F. Otvagin, Lubov V. Krylova, Nina N. Peskova, Natalia S. Kuzmina, Ekaterina A. Fedotova, Alexander V. Nyuchev, Yuliya V. Romanenko, О. И. Койфман, Sergey Z. Vatsadze, Hans‐Günther Schmalz, Irina V. Balalaeva, Alexey Yu. Fedorov

2024European Journal of Medicinal Chemistry16 citationsDOI

Topics & Concepts

Photodynamic therapyChemistryConjugateProdrugCancer researchPhotosensitizerLinkerIn vitroTumor microenvironmentPharmacologyBiochemistryBiologyTumor cellsPhotochemistryOrganic chemistryMathematical analysisOperating systemComputer scienceMathematicsPhotodynamic Therapy Research StudiesNanoplatforms for cancer theranosticsCancer Research and Treatments
A first-in-class β-glucuronidase responsive conjugate for selective dual targeted and photodynamic therapy of bladder cancer | Litcius